Guyana Health Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guyana Health Review.

Press releases published on August 21, 2026

AI Disrupts Gas Separation Membrane Design, Unlocking CO₂ Selectivity Gains of Up to 25% and Cutting Development Timelines by 40%
Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets
SK pharmteco nimmt an der CPHI teil und präsentiert dort seine multimodalen CDMO-Kompetenzen sowie seine globale Produktionsinfrastruktur
SK pharmteco participera au salon CPHI et présentera ses capacités de CDMO multimodales ainsi que son infrastructure mondiale de fabrication
RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement
Synergy CHC Corp. Announces Receipt of Nasdaq Letter
Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 million Private Placement
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 Million Private Placement
Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer
Avance Clinical Appoints Inaugural Chief Commercial Officer, Reinforcing Global Growth Strategy
PharmAla Biotech Provides Corporate Update: U.S. Patent Granted Covering Novel Enantioselective Processes, Decision on APA-01, and Engagement of Canaccord Genuity as Exclusive Investment Banking Partner
NICE Supports Routine NHS Funding and Access to Ex-Situ Machine Perfusion in a Major Step Forward for Liver Transplantation
Bavarian Nordic leverer et stærkt regnskab for første halvår 2026
Bavarian Nordic Reports Strong First Half 2026 Results
Ipsen finalise l'acquisition de Kartos Therapeutics, renforçant son portefeuille d'oncologie en phase avancée
Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline
Aveanna Announces Pricing of Secondary Offering of Common Stock

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Guyana Health Review

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.